Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Private Sector Involvement

  • your selections
Clear Search

Filter Results

date

Tags

  • results
Also In Global Health News: Reproductive Health In Philippines; Microfinance Debt In India; HIV/AIDS In Kenya; Google’s DotOrg

Reproductive Health Bill Is Approved By Philippines House Of Representatives IRIN reports a “hotly debated” bill “that proposes national funding for, and access to, reproductive healthcare services and products,” cleared “a major hurdle on [Monday] after being approved by a committee of the Philippines House of Representatives” (2/1). Biliran Rep. Rogelio…

Johnson & Johnson Deal May Bring HIV/AIDS Drugs To Developing Countries Faster

Johnson & Johnson’s Tibotec Pharmaceuticals unit on Thursday announced it granted multiple licenses to generic drug manufacturers” to provide copies of [the experimental HIV/AIDS drug rilpivirine hydrochloride] TMC278 in sub-Saharan Africa, India and parts of Asia if it’s approved by regulators,” Bloomberg Businessweek reports.

Recent Releases In Global Health

Innovative Health Financing Can Benefit Global Health, Pharma: “The launch of pneumococcal vaccination in Nicaragua under AMC [advance market commitment] has shown that innovative approaches to health financing can benefit both global health and pharmaceutical companies,” according to a Lancet Infectious Diseases editorial that describes how the roll-out of GAVI initiative…

Merck, Wellcome Trust Back Project To Develop Improved Rotavirus Vaccine For Developing Countries

“A joint venture between U.S. drugmaker Merck and Britain’s Wellcome Trust charity said on Monday it is working on an oral rotavirus vaccine designed to be cheaper and easier to use than current shots,” Reuters reports. “Hilleman Laboratories, an India-based joint venture set up on a not-for-profit basis in 2009, said the vaccine will aim to protect against diarrhea-causing rotavirus infections and will be based on thin strips or granules that dissolve in the mouth and can be easily transported, stored and administered.”

U.S., China Announce Public-Private Health Care Partnership

In conjunction with the state visit to the U.S. by Chinese President Hu Jintao, the U.S. Department of Health and Human Services (HHS) and several other federal agencies on Wednesday announced a new public-private health care partnership between the U.S. and China, Modern Healthcare reports (Blesch, 1/19).

RTS,S Offers 46 Percent Protection Against Malaria For At Least 15 Months After Vaccination, Study Finds

A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the “experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection” against malaria, Reuters reports. “Scientists conducting the mid-stage trial at the Kenya Medical Research Institute said results showing the shot offered 46 percent protection for 15 months meant it had ‘promise as a potential public health intervention against childhood malaria in malaria endemic countries’,” the news service notes (Kelland, 1/14).

Recent Releases

‘Ethical Issues Raised By PrEP Are Difficult, But Not Insurmountable’: “The AIDS movement is at a pivotal point in history, where it will face scrutiny not only to demonstrate that interventions are cost-effective and equitably distributed, but also to balance resource demands with other global health imperatives, such as maternal/child…

Also In Global Health News: NGOs, Business Schools; India’s Growing Presence In Africa; Water, Sanitation In Indonesia; Malaria Vaccine Trials

Financial Times Reports On Oxfam’s MBA Workshops Financial Times explores how the NGO Oxfam has started to “develop ethical trade workshops for MBA students in UK business schools, with a particular focus on overseas students” in the “hopes that by targeting the next generation of business leaders, it can influence…